Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 12/54
Susan
Collins
U.S. Senate · R-ME
Taken from pharma & insurers
$112,632
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 12/54
Pharma & Health$70,212
Insurers & HMOs$42,420
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 12 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$112,632
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Through the leadership PAC
Beyond the campaign account, a leadership PAC under Collins's control (Dirigo PAC) took $377,773 from banks, card lenders, drug makers and insurers.
Source: FEC; Dirigo PAC
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
★ Hall of Shame
Collins voted with the money in more than one set:
Don't recognize a logo? Here's the key.
Pharma & Health$70,212
Johnson & Johnson$39,748
Pfizer$13,450
PhRMA$7,000
Bristol Myers Squibb$4,200
Amgen$3,000
Merck$2,564
AbbVie$250
Insurers & HMOs$42,420
Aetna$16,185
Anthem/Elevance$13,500
Cigna$9,635
Centene$2,800
CVS Health$300